News
Sigachi Industries' shares slipped 8.19% to Rs 54.05 on BSE. Dishman Carbogen Amcis shares fell 5% to Rs 260.55 against the ...
GlaxoSmithKline Pharmaceuticals, with its shares currently priced at Rs 3,292.30, remains a key stock to watch, particularly ...
It has been dubbed a “Trojan horse” treatment because it works by being taken into a cancer cell, before releasing a high ...
This Original Lifetime Movie, "Pretty Hurts," airs June 28, at 8 p.m.
What if you could actually see where a drug travels in the body down to the cellular level. Find out how mass spectrometry ...
content.api.pressassociation.io on MSN5d
‘Trojan horse’ treatment given green light for NHS useUse precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...
IPV Vaccines Market Set to Expand at CAGR of 8.7% Through 2032 | Sanofi Pasteur, GlaxoSmithKline plc
The global IPV vaccines market is estimated to be valued at USD 199.9 Mn in 2025 and expected to reach at USD 358.5 Mn by 2032 With a CAGR of 8.7% during the forecast period (2025-2032). Coherent ...
A talk with study author on a new combination of acimtamig and an allogeneic natural killer cell product that shows safety ...
Dozens of states are suing to block 23andMe's sale of personal genetic data, citing concerns over customer consent and ...
Moderna vaulted to the forefront of biotech, becoming a major pillar of the region’s economy. But Robert F. Kennedy Jr.’s ...
For patients with advanced or recurrent endometrial cancer, dostarlimab plus carboplatin-paclitaxel treatment is associated ...
As with the drug's 2023 approval in castration-resistant tumors, it's not clear if it works comparably in all homologous ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results